TY - JOUR
T1 - Carcinogenicity of 2,2'-dihydroxy-di-n-propylnitrosamine in the tree shrew (Tupaia glis)
T2 - Light and electron microscopic features of pulmonary adenomas
AU - Musunuri, Sambasiva Rao
AU - Reddy, Janardan K
PY - 1980/1/1
Y1 - 1980/1/1
N2 - The carcinogenic effect of 2,2'-dihydroxy-di-n-propyinitrosamine (DHPN) was examined in the primitive primate, tree shrew (Tupaia glis). DHPN was administered at a dose of 250 mg/kg body weight sc once a week for 80 weeks. Between 65 and 102 weeks, 8 of 9 males given DHPN (89%) and 11 of 14 females given DHPN (78%) developed pulmonary adenomas. In 2 DHPN-treated males, in addition to adenomas, bronchioalveolar carcinomas were observed. Transmission electron microscopic examination of pulmonary adenomas from 4 DHPN-treated animals showed that Clara cells were the main components of these tumors. In addition to pulmonary tumors, 9% of the DHPN-treated animals developed squamous cell carcinomas of the skin and hepatocellular carcinomas. None of the 6 controls, which received olive oil alone, developed any tumors.
AB - The carcinogenic effect of 2,2'-dihydroxy-di-n-propyinitrosamine (DHPN) was examined in the primitive primate, tree shrew (Tupaia glis). DHPN was administered at a dose of 250 mg/kg body weight sc once a week for 80 weeks. Between 65 and 102 weeks, 8 of 9 males given DHPN (89%) and 11 of 14 females given DHPN (78%) developed pulmonary adenomas. In 2 DHPN-treated males, in addition to adenomas, bronchioalveolar carcinomas were observed. Transmission electron microscopic examination of pulmonary adenomas from 4 DHPN-treated animals showed that Clara cells were the main components of these tumors. In addition to pulmonary tumors, 9% of the DHPN-treated animals developed squamous cell carcinomas of the skin and hepatocellular carcinomas. None of the 6 controls, which received olive oil alone, developed any tumors.
UR - http://www.scopus.com/inward/record.url?scp=0018822557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018822557&partnerID=8YFLogxK
U2 - 10.1093/jnci/65.4.835
DO - 10.1093/jnci/65.4.835
M3 - Article
C2 - 6252363
AN - SCOPUS:0018822557
SN - 0027-8874
VL - 65
SP - 835
EP - 840
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 4
ER -